Back
Aptevo Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
22
APVO
Aptevo Therapeutics
Last Price:
$2.95
Seasonality Move:
-28.18%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.01 | Sell |
| 20-day SMA: | 3.42 | Sell |
| 50-day SMA: | 5.2 | Sell |
| 200-day SMA: | 79.44 | Sell |
| 8-day EMA: | 3.07 | Sell |
| 20-day EMA: | 3.59 | Sell |
| 50-day EMA: | 9.05 | Sell |
| 200-day EMA: | 887.95 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 34.85 | Sell |
| Chaikin Money Flow: | 92395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.89 - 4.47) | Sell |
| Bollinger Bands (100): | (0.04 - 44.74) | Sell |
Aptevo Therapeutics Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 3.00 while APVO 8-day simple moving average is 3.01, which is a Sell signal.
-
The stock price of APVO is 3.00 while Aptevo Therapeutics 20-day SMA is 3.42, which makes it a Sell.
-
Aptevo Therapeutics 50-day simple moving average is 5.20 while APVO share price is 3.00, making it a Sell technically.
-
APVO stock price is 3.00 and Aptevo Therapeutics 200-day simple moving average is 79.44, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
22
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $3.00. The Score for APVO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2M
Price in USD:
3.00
Share Volume:
129.4K
Aptevo Therapeutics 52-Week Range
52-Week High:
485.37
52-Week Low:
2.81
Sell
22
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?The Aptevo Therapeutics stock price is 3.00 USD today.
-
Will APVO stock go up or go down?Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aptevo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 3.00 while APVO 8-day exponential moving average is 3.07, which is a Sell signal.
-
The stock price of APVO is 3.00 while Aptevo Therapeutics 20-day EMA is 3.59, which makes it a Sell.
-
Aptevo Therapeutics 50-day exponential moving average is 9.05 while APVO share price is 3.00, making it a Sell technically.
-
APVO stock price is 3.00 and Aptevo Therapeutics 200-day simple moving average is 887.95, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $346.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1,402.40 per share, and an increase next year of $27.00 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
-
APVO Moving Average Covergence Divergence (MACD) indicator is -0.94, suggesting Aptevo Therapeutics is a Sell
-
Aptevo Therapeutics Relative Strength Index (RSI) is 34.85, which suggest Aptevo Therapeutics is oversold
-
The Bollinger Bands (25) for Aptevo Therapeutics is (2.89 - 4.47), which suggest Aptevo Therapeutics is a Sell
-
The Bollinger Bands (100) for Aptevo Therapeutics is (0.04 - 44.74), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.